The Pdcd4 gene has originally been isolated in a search for genes that are activated in cells undergoing apoptosis. Independent of these studies, the Pdcd4 gene has been implicated in the suppression of tumor-promoter-mediated transformation of keratinocytes and as a downstream target of Myb in hematopoietic cells. The Pdcd4 protein has weak homology to the eucaryotic translation initiation factor eIF4G and has been shown to interact with certain translation initiation factors. To explore the molecular function of the Pdcd4 protein, we have studied its subcellular localization. We show that the Pdcd4 protein is a predominantly nuclear protein under normal growth conditions and that it is exported from the nucleus by a leptomycin B-sensitive mechanism upon serum withdrawal. The protein contains two nuclear export signals, one of which is very potent. In addition, we demonstrate that the Pdcd4 protein has RNA-binding activity and that the sequences involved in RNA-binding are located in the amino-terminal part of the protein. Taken together, our data raise the possibility that Pdcd4 is involved in some aspect of nuclear RNA metabolism in addition to its suspected role in protein translation.
The Pdcd4 gene has originally been isolated in a search for genes that are activated in cells undergoing apoptosis. Independent of these studies, the Pdcd4 gene has been implicated in the suppression of tumor-promoter-mediated transformation of keratinocytes and as a downstream target of Myb in hematopoietic cells. The Pdcd4 protein has weak homology to the eucaryotic translation initiation factor eIF4G and has been shown to interact with certain translation initiation factors. To explore the molecular function of the Pdcd4 protein, we have studied its subcellular localization. We show that the Pdcd4 protein is a predominantly nuclear protein under normal growth conditions and that it is exported from the nucleus by a leptomycin B-sensitive mechanism upon serum withdrawal. The protein contains two nuclear export signals, one of which is very potent. In addition, we demonstrate that the Pdcd4 protein has RNA-binding activity and that the sequences involved in RNA-binding are located in the amino-terminal part of the protein. Taken together, our data raise the possibility that Pdcd4 is involved in some aspect of nuclear RNA metabolism in addition to its suspected role in protein translation. Oncogene (2003 Oncogene ( ) 22, 4905-4910. doi:10.1038 Keywords: Pdcd4; nuclear export signals; RNA-binding; Myb target gene The Pdcd4 gene (also known as MA-3, TIS, H731 and DUG) was originally identified by screening for genes whose expression is upregulated during apoptosis (Shibahara et al., 1995) . However, most of the recent interest in the gene stems from the observation that Pdcd4 acts as a transformation suppressor in mouse keratinocytes (Cmarik et al., 1999) . Pdcd4 expression was found to be high in a keratinocyte cell line that was resistant to transformation by the tumor promoter PMA and low in a related cell line that was efficiently transformed in the presence of the tumor promoter. Upregulation of Pdcd4 rendered the cells resistant to transformation by the tumor promoter, whereas antisense-mediated downregulation of Pdcd4 resulted in higher transformation rates. Furthermore, it was shown that Pdcd4 inhibits AP-1-dependent transactivation by an unknown mechanism (Yang et al., 2001) . Together, these findings suggested that the Pdcd4 gene might somehow affect signal transduction pathways that are triggered by tumor promoters and lead to the activation of the transcription factor AP-1. Our own studies have independently identified the chicken Pdcd4 gene as a direct target gene of the transcription factor c-Myb (Schlichter et al., 2001a; Appl and Klempnauer, 2002) . c-Myb is essential for the development of the hematopoietic system and is considered to be part of a molecular switch that directs hematopoietic progenitor cells to alternative fates, such as proliferation, differentiation and apoptosis (Lipsick and Wang, 1999; Oh and Reddy, 1999; Weston, 1999) . The Pdcd4 gene is directly regulated by Myb and its promoter contains several consensus Myb-binding sites (Schlichter et al., 2001b) . Within the hematopoietic system Pdcd4 is expressed in a broad spectrum of hematopoietic cell types (Schlichter et al., 2001a) . Thus, its role in hematopoietic cells appears not to be restricted to particular hematopoietic lineages, making it a particularly interesting Myb target gene.
How Pdcd4 exerts its effects is not clear. The Pdcd4 protein has recently been shown to interact with eucaryotic translation initiation factors (eIFs) eIF4A and eIF4G (Go¨ke et al., 2002; Kang et al., 2002; Yang et al., 2003) , suggesting that it might be involved in regulating protein translation. In support of this idea, Yang et al. (2003) have localized the protein to the cytoplasm and have demonstrated that it inhibits the helicase activity of eIF4A and cap-dependent translation. Using cells transiently transfected with a Pdcd4 expression vector, we have previously localized the Pdcd4 protein to the cell nucleus (Schlichter et al., 2001a) . Furthermore, in another study the protein was detected in the cytoplasm or in the nucleus, depending on the type of cells or their growth state . These observations suggest that in addition to its suspected function in protein translation, the Pdcd4 protein, may have a role in the nucleus as well. To address the apparent discrepancies in the subcellular localization of the Pdcd4 protein, we transfected QT6 fibroblasts (Moscovici et al., 1977) with an expression vector for HA-tagged Pdcd4 and isolated clones of stable transfectants expressing the protein. Immunofluorescence analysis of a representative clone (referred to as clone 31.4) with HA-specific antibodies showed prominent nuclear fluorescence in most of the cells, confirming that the Pdcd4 protein resides primarily in the nucleus (Figure 1b) . With the exception of the nucleoli, which were stained less intensely, the staining pattern suggested a relatively uniform distribution of the Pdcd4 protein within the nucleus. In particular, there were no obvious nuclear speckles visible. Untransfected cells showed only background staining (Figure 1a) .
Inspection of the deduced amino-acid sequence of the Pdcd4 protein revealed two potential nuclear export signals (NESs) (see Figure 2a) , suggesting that the Pdcd4 protein might be able to shuttle back to the cytoplasm under certain conditions. To explore this possibility, we subjected clone 31.4 cells to various treatments and analysed the subcellular location of the Pdcd4 protein.
Since the Pdcd4 gene has been implicated in apoptosis and in the inhibition of TPA-induced transformation of keratinocytes (Cmarik et al., 1999) , we investigated whether induction of apoptosis, or activation or inhibition of protein kinase C would alter the localization of the Pdcd4 protein. However, none of these treatments had any effect (data not shown). In the course of these studies, however, we discovered that withdrawal of serum from the growth medium resulted in a marked loss of nuclear fluorescence (Figure 1d ). The protein was not degraded under these conditions, as shown by Western blotting (data not shown) suggesting that the protein is redistributed in the cell in the absence of serum.
As pointed out above, the Pdcd4 protein contains two sequences that are similar to leucine-rich NESs of proteins known to be exported from the nucleus (Figure 2a ). Nuclear export of NES-containing proteins is usually mediated by the nuclear export receptor CRM1 and can specifically be inhibited by leptomycin B (LMB) (Nishi et al., 1994; Fornerod et al., 1997; Fukuda et al., 1997) . To investigate whether the Pdcd4 protein is exported from the nucleus by a CRM1-dependent mechanism in the absence of serum, we treated the cells with LMB. As shown in Figure 1e , in the presence of LMB the protein remained in the nucleus upon serum withdrawal. We therefore concluded that the Pdcd4 protein is exported from the nucleus in the absence of serum.
To investigate whether the sequences shown in Figure 2a are indeed active as nuclear export sequences, we fused them to glutathione-S-transferase (GST). The resulting fusion proteins were then labeled with the fluorescent dye Alexa Fluor 488 and microinjected into the nuclei of NIH3T3 fibroblasts, followed by the analysis of their distribution in the cell. As control, a high-molecular-weight dextran labeled with Texas Red (TRD70) was coinjected to monitor unspecific leakage from the injected nuclei. As shown in Figure 2c , both fusion proteins (referred to as GST-NES1 and GST-NES2) were exported from the injected nuclei, whereas the high-molecular-weight dextran remained in the nucleus. The specificity of the nuclear export was assessed by coinjection with LMB and by mutating critical leucine residues in the nuclear export sequences (Figure 2c ). LMB abolished nuclear export of GST-NES1 and GST-NES2 completely. Likewise, mutation of NES1 destroyed its activity completely, while the mutated version of NES2 was still partially active, presumably because of the high inherent export activity of NES2. That NES2 is particularly effective in mediating nuclear export was also demonstrated by a time course experiment (Figure 3 ). This experiment showed that the export activity of NES2 was similar to that of the very potent NES of the heat-stable inhibitor of the cAMP-dependent protein kinase (referred to as PKI-NES) (Wen et al., 1995; Henderson and Eleftheriou, 2000) . Taken together, these experiments clearly demonstrate that the Pdcd4 protein contains two NESs, one of which is particularly effective.
The finding that the Pdcd4 protein interacts with eIFs (Go¨ke et al., 2002; Kang et al., 2002; Yang et al., 2003) suggested that it might be involved in some aspect of RNA metabolism. We were therefore interested to see whether the Pdcd4 protein is an RNA-binding protein.
As a first step to address this issue, we determined the ability of the protein to bind to agarose carrying covalently bound poly-adenylic acid (poly[A]). As QT6 cells stably expressing HA-tagged Pdcd4 (clone 31.4) (b) or the parental QT6 cells (a) were grown on glass coverslips and analysed by immunofluorescence as described (Schlichter et al., 2001a) . Immunostaining was performed with the HA-specific monoclonal antibody HA.11 (BAbCO) and rhodamine-coupled anti-mouse antibodies (Roche Diagnostics). (c-e). Clone 31.4 cells were grown in regular growth medium (c), serum-starved for 3 h (d) or serumstarved for 3 h in the presence of 4 ng/ml LMB (e) and analysed by immunofluorescence microscopy using anti-HA antibodies shown in Figure 4a , when an extract from clone 31.4 cells was subjected to chromatography on poly [A] agarose, a substantial fraction of the protein bound to the column and could be released by increasing the salt concentration, suggesting that the Pdcd4 protein has RNA-binding activity. The fact that only a fraction of the protein bound to the agarose might be due to the presence of free RNA present in the crude cell extract. To demonstrate that Pdcd4 has intrinsic RNA-binding activity and to exclude the possibility that the binding observed in Figure 4a is mediated by other eucaryotic proteins, we generated a bacterially expressed full-length mouse Pdcd4/GST fusion protein. As shown in Figure 4b , the purified protein very efficiently bound to poly [A] agarose in the absence of other eucaryotic proteins. As an alternative approach to demonstrate that the Pdcd4 protein has RNA-binding activity and to map its RNA-binding domain, we generated GST fusion proteins of partially deleted Pdcd4 in addition to the full-length protein. These proteins were purified, run on SDS-polyacrylamide gels, blotted onto nitrocellulose and incubated with radiolabeled RNA transcribed in vitro. As illustrated in Figure 4c , the full-length Pdcd4 were purified on glutathione-sepharose, eluted by an excess of glutathione, dialyzed and labeled with Alexa488 (C 5 -Maleimid; Molecular Probes) in 20 mm Tris-HCl pH 7.4, 50 mm NaCl, 2 mm MgCl 2 and incubation on ice overnight. Unbound dye was removed by gel filtration (Biogel P-6; Bio-Rad). Texas-Red-labeled dextran (molecular weight 70 kDa, TRD70) was obtained from Molecular Probes (Leiden, The Netherlands). Samples to be injected were prepared in 50 mm HEPES, pH 7.3; 0.11 mm potassium acetate; 1 mm EGTA; 5 mm sodium acetate; 2 mm magnesium actetate; 2 mm DTT and contained between 3.6 and 5 mg/ml labeled GST protein and 1 mg/ml of TRD70. After microinjection, the cells were incubated for 1 h in growth medium at 371C and the distibution of labeled proteins and dextran was then analysed in a confocal immunofluorescence microscope. In some experiments, GST-NES fusion proteins were coinjected with LMB. As an additional control, a GST protein carrying the NES of protein kinase A inhibitor, referred to as PKI-NES ( (Figure 4d ). It is evident that Pdcd4 binds RNA also under these conditions. In contrast, the truncated protein tested in parallel shows only background binding. The Pdcd4 gene has attracted interest recently because of its potential role as a tumor-suppressor gene (Cmarik et al., 1999) . Pdcd4 is highly conserved among different vertebrates; furthermore, homologs have been found in the fruitfly Drosophila melanogaster (GenBank name CG10990) as well as in the sponge Suberites domuncula (Wagner et al., 1998) , suggesting that it has been highly conserved during evolution and, thus, may play an important role. Although the molecular function of the Pdcd4 gene is not well known at present, some aspects of its function are beginning to emerge. Recent work has shown that the Pdcd4 protein interacts with eIFs, eIF4A and eIF4G, inhibits the RNA helicase activity of eIF4A in vitro and cap-dependent translation, thus implicating the Pdcd4 protein in protein translation (Go¨ke et al., Kang et al., 2002; Yang et al., 2003) . The data presented here reveal two novel aspects of Pdcd4 function. Firstly, they suggest that the Pdcd4 protein is able to shuttle between nucleus and cytoplasm. Under normal growth conditions, the Pdcd4 protein is located predominantly in the nucleus. Although a nuclear localization signal has not been formally identified, the apparent molecular weight of the Pdcd4 protein of approximately 60 kDa strongly suggests that it is actively transported into the nucleus. Two potential nuclear localization signals, KAKRRLR and PSRGRKR, are found close to the amino terminus and carboxy terminus of the protein, respectively. In contrast to normal growth conditions, in cells depleted of serum most of the Pdcd4 protein is found in the cytoplasm. LMB, an inhibitor of Crm1-dependent nuclear export, prevents loss of Pdcd4 from the nucleus following serum depletion, indicating that the protein is actively exported from the nucleus under these conditions. Consistent with this idea, we have shown that the Pdcd4 protein contains two NESs, each of which mediates efficient nuclear export of a heterologous protein in an LMB-sensitive manner. Although one of the NESs was extremely potent, most of the Pdcd4 protein is located in the nucleus under normal growth conditions. It therefore appears that the Pdcd4-NES sequences are functionally blocked in the context of the full-length protein or that nuclear export is counteracted by efficient import. In any case, the balance between import and export is altered under conditions of serum withdrawal, suggesting that the subcellular localization of the protein is controlled by external signals. The identity of these signals is not known at present; however, the Pdcd4 amino-acid sequence contains potential phosphorylation sites for proline-directed protein kinases, casein kinase II and protein kinase C, which could be involved in modulating nuclear import or export of the Pdcd4 protein in response to external signals.
Secondly, our data show that the Pdcd4 protein is able to bind to RNA. The amino-acid sequences involved in RNA binding are located in the aminoterminal region of the protein. This region of the protein is very hydrophilic and contains stretches of positively and negatively charged amino acids. In particular, there are two regions (centered around amino acids 60 and 100) that contain several clustered arginine residues, suggesting that the Pdcd4 protein might be related to the arginine-rich RNA-binding proteins (for review, see Patel, 1999; Weiss and Narayana, 1999; Perez-Canadillas and Varani, 2001) . RNA binding appears to be direct and not to require additional proteins or an m 7 G cap, as demonstrated by using bacterially expressed Pdcd4 protein and in vitro synthesized uncapped RNA. Although most eIFs are located in the cytoplasm, certain eIFs appear to have additional functions in the nucleus. For example, eIF4G has been identified as part of the nuclear cap binding complex (McKendrick et al., 2001) . Furthermore, there is evidence that nuclear translation occurs as part of the nonsense-mediated decay mechanism, which detects nonsense codons during a pioneer round of translation (for review, see Hentze and Kuloznik, 1999; Lykke-Andersen, 2001; Maquat and Carmichael, 2001; Schell et al., 2002) . Owing to its RNA-binding activity, its homology to eIF4G and its interaction with other eIFs, it is tempting to speculate that the Pdcd4 protein might be involved in these or other RNA-processing events, such as splicing or nucleocytoplasmic transport. Since in our hands Pdcd4 expression appears to have no global effect on protein synthesis (unpublished observations), it will be very interesting to see whether Pdcd4 affects specific RNAs or the synthesis of specific proteins.
In summary, our data raise the interesting possibility that in addition to its suspected role in cytoplasmic protein translation, the Pdcd4 protein is involved in some aspect of RNA metabolism, transport or processing. Our data also suggest that, in addition to its direct transcriptional effects on gene expression, Myb may affect proliferation and differentiation of hematopoietic cells also indirectly at the post-transcriptional level.
